Odyssey Health (ODYY) Income towards Parent Company (2014 - 2026)
Odyssey Health's quarterly Income towards Parent Company came in at -$594371.0 in Q1 2026, down 170.14% year-on-year from $847416.7 in Q1 2025, and down 49.14% quarter-over-quarter from -$398526.0 in Q4 2025.
Odyssey Health has reported Income towards Parent Company for 13 years, with the latest figure at -$594371.0 in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company fell 170.14% year-over-year to -$594371.0; the trailing twelve-month figure through Jan 2026 stood at -$1.4 million (down 17.55% YoY), and the FY2025 full-year result was -$1.3 million, up 52.1% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$594371.0, down from -$398526.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $153644.0 in Q3 2024, with the low at -$3.1 million in Q2 2022.
- Average Income towards Parent Company over 5 years is -$1.0 million, with a median of -$648208.0 recorded in 2024.
- Year-over-year, Income towards Parent Company surged 118.87% in 2024 and sank 239.66% in 2025.
- Tracing ODYY's Income towards Parent Company over 5 years: stood at -$2.1 million in 2022, then jumped by 74.96% to -$538100.0 in 2023, then dropped by 20.46% to -$648208.0 in 2024, then jumped by 38.52% to -$398526.0 in 2025, then sank by 49.14% to -$594371.0 in 2026.
- The last three Income towards Parent Company figures came in at -$594371.0 (Q1 2026), -$398526.0 (Q4 2025), and -$214583.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -594,371.00 |
| Oct 31, 2025 | -398,526.00 |
| Jul 31, 2025 | -214,583.00 |
| Apr 30, 2025 | -190,450.00 |
| Jan 31, 2025 | -220,024.00 |
| Oct 31, 2024 | -648,208.00 |
| Jul 31, 2024 | 153,644.00 |
| Apr 30, 2024 | -474,598.00 |
| Jan 31, 2024 | -1.30 Mn |
| Oct 31, 2023 | -538,100.00 |
| Jul 31, 2023 | -814,284.00 |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.68 Mn |
| Oct 31, 2022 | -2.15 Mn |
| Jul 31, 2022 | -2.01 Mn |
| Apr 30, 2022 | -3.10 Mn |
| Jan 31, 2022 | -2.18 Mn |
| Oct 31, 2021 | -1.65 Mn |
| Jul 31, 2021 | -2.90 Mn |
| Apr 30, 2021 | -12.45 Mn |
| Jan 31, 2021 | -869,299.00 |
| Oct 31, 2020 | -711,514.00 |
| Jul 31, 2020 | -1.33 Mn |
| Apr 30, 2020 | -999,275.00 |
| Jan 31, 2020 | -600,945.00 |
| Oct 31, 2019 | -1.42 Mn |
| Jul 31, 2019 | -23.41 Mn |
| Apr 30, 2019 | -62,769.00 |
| Jan 31, 2019 | -106,472.00 |
| Oct 31, 2018 | -69,496.00 |
| Jul 31, 2018 | -98,899.00 |
| Apr 30, 2018 | -73,567.00 |
| Jan 31, 2018 | -247,241.00 |
| Oct 31, 2017 | -63,408.00 |
| Jul 31, 2017 | -64,789.00 |
| Apr 30, 2017 | -80,012.00 |
| Jan 31, 2017 | -31,173.00 |
| Oct 31, 2016 | -21,870.00 |
| Jul 31, 2016 | -36,835.00 |
| Apr 30, 2016 | -8,184.00 |
| Jan 31, 2016 | -16,104.00 |
| Oct 31, 2015 | -24,994.00 |
| Jul 31, 2015 | -24,058.00 |
| Apr 30, 2015 | -42,496.00 |
| Jan 31, 2015 | -50,665.00 |
| Oct 31, 2014 | -43,479.00 |